# Frog Skin Peptides: Nature’s Dual-Action Weapons Against Infection and Cancer

**Authors:** Eleonora Grisard, Carlo Vetrano, Ali Benour, Eeva Tortellini, Dania Al Ismail, Giacomo Cappella, Bruno Casciaro, Maria Luisa Mangoni, Milena Mechkarska

PMC · DOI: 10.3390/antibiotics15030324 · Antibiotics · 2026-03-23

## TL;DR

Frog skin peptides show promise as dual-action treatments for both infections and cancer due to their unique properties and mechanisms.

## Contribution

This review identifies and emphasizes frog skin peptides with dual antimicrobial and anticancer properties and their translational potential.

## Key findings

- Frog skin peptides like dermaseptins, temporins, and brevinins disrupt microbial membranes and induce cancer cell death.
- Key features like net positive charge and α-helical conformation contribute to their dual functionality.
- Peptide engineering and delivery advances have improved their stability and therapeutic potential.

## Abstract

The rise of antimicrobial resistance and the global burden of cancer demand innovative therapeutic strategies. Frog skin secretions offer a rich source of bioactive peptides, some of which exhibit remarkable dual functionality—potent antimicrobial activity coupled with selective anticancer effects. This review highlights frog skin-derived peptides that bridge the gap between antimicrobial and anticancer therapeutics, emphasizing their structural diversity, mechanisms of action, and translational potential. A comprehensive literature search was conducted to identify peptides isolated from diverse anuran species, with emphasis on studies reporting structural features, activity against Gram-positive and Gram-negative bacteria, including multidrug resistant clinical isolates, anticancer effects, and underlying molecular mechanisms of cytotoxicity. Peptides such as dermaseptins, temporins, and brevinins disrupt microbial membranes while triggering apoptosis or necrosis in cancer cells. Key physicochemical characteristics, including net positive charge, amphipathicity, and α-helical conformation, contribute to their dual functionality. Recent advances in peptide engineering and delivery have improved stability, selectivity, and therapeutic efficacy, enhancing the clinical prospects of these naturally occurring bioactive molecules. Frog skin peptides represent promising candidates for the development of next-generation antimicrobial and anticancer therapeutics.

## Linked entities

- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Genes:** Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Cd69 (CD69 antigen) [NCBI Gene 12515] {aka 5830438K24Rik, AIM, VEA}, COL11A2 (collagen type XI alpha 2 chain) [NCBI Gene 1302] {aka DFNA13, DFNB53, FBCG2, HKE5, OSMEDA, OSMEDB}, Cd247 (CD247 antigen) [NCBI Gene 12503] {aka 4930549J05Rik, A430104F18Rik, Cd3, Cd3-eta, Cd3-zeta, Cd3h}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, lactate dehydrogenase [NCBI Gene 28379807], Trp53-ps (transformation related protein 53, pseudogene) [NCBI Gene 22060], Bax (BCL2-associated X protein) [NCBI Gene 12028], TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Itgax (integrin alpha X) [NCBI Gene 16411] {aka Cd11c, Cr4, N418}, Lamp1 (lysosomal-associated membrane protein 1) [NCBI Gene 16783] {aka CD107a, LGP-120, LGP-A, Lamp-1, P2B, Perk}, Fasl (Fas ligand) [NCBI Gene 14103] {aka APT1LG1, CD178, CD95-L, CD95L, Fas-L, Faslg}, Il23a (interleukin 23, alpha subunit p19) [NCBI Gene 83430] {aka IL-23, p19}, CASP8 (caspase 8) [NCBI Gene 841] {aka ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5}, Casp3 (caspase 3) [NCBI Gene 12367] {aka A830040C14Rik, AC-3, CASP-3, CC3, CPP-32, CPP32}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, Anxa5 (annexin A5) [NCBI Gene 11747] {aka Anx5, CPB-I}, ANXA5 (annexin A5) [NCBI Gene 308] {aka ANX5, CPB-I, ENX2, HEL-S-7, PP4, RPRGL3}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Mprf (maternal performance) [NCBI Gene 492910], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, AKT3 (AKT serine/threonine kinase 3) [NCBI Gene 10000] {aka MPPH, MPPH2, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma}, Klrk1 (killer cell lectin-like receptor subfamily K, member 1) [NCBI Gene 27007] {aka D6H12S2489E, NKG2-D, Nkg2d}
- **Diseases:** oral squamous cell carcinoma (MESH:D000077195), lung squamous cell carcinoma (MESH:D002294), ovarian cancer (MESH:D010051), osteosarcoma (MESH:D012516), COVID-19 (MESH:D000086382), T cell leukemia (MESH:D015458), B cell lymphoma (MESH:D016393), inflammation (MESH:D007249), breast and lung cancer (MESH:D001943), necrosis (MESH:D009336), hypoxia (MESH:D000860), glioblastoma (MESH:D005909), Cancer (MESH:D009369), P388 leukemia (MESH:D007941), viral infections (MESH:D014777), opportunistic infections (MESH:D009894), ascites (MESH:D001201), hemolytic (MESH:D006461), Melanoma (MESH:D008545), ovarian teratoma (MESH:C562731), fibrosarcoma (MESH:D005354), mitochondrial (MESH:D028361), lung (MESH:D008171), histiocytic lymphoma (MESH:D016403), inflammatory cytokines (MESH:D000080424), oncologic (MESH:D000072716), cytotoxic (MESH:D064420), NSCLC (MESH:D002289), cervical, gastric, and hepatic cancer (MESH:D013274), cervical cancer (MESH:D002583), hepatoma (MESH:D006528), bladder cancer (MESH:D001749), Ehrlich ascites murine carcinoma (MESH:D002286), hepatic cancer (MESH:D008113), fungal (MESH:D009181), prostate cancer (MESH:D011471), A549 lung cancer (MESH:D008175), deaths (MESH:D003643), carcinogenesis (MESH:D063646), bacterial infections (MESH:D001424), gallbladder cancer (MESH:D005706), leukemia (MESH:D007938), tumor-derived (MESH:C536408), microbial infection (MESH:D015163), injury to (MESH:D014947), Infection (MESH:D007239), sarcoma (MESH:D012509), small cell lung cancer (MESH:D055752)
- **Chemicals:** phosphatidic acid (MESH:D010712), MTT (MESH:C070243), AMP (MESH:D000089882), proline (MESH:D011392), LPS (MESH:D008070), ATP (MESH:D000255), histidine (MESH:D006639), peptides (MESH:D010455), H2O2 (MESH:D006861), PI (MESH:D010716), phospholipid (MESH:D010743), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MESH:C022616), ROS (MESH:D017382), phosphatidylserine (MESH:D010718), phosphatidylcholine (MESH:D010713), lysine (MESH:D008239), neutral red (MESH:D009499), 5-fluorouracil (MESH:D005472), darobactin (MESH:C000718067), lipid (MESH:D008055), cisplatin (MESH:D002945), agar (MESH:D000362), doxorubicin (MESH:D004317), arginine (MESH:D001120), cholesterol (MESH:D002784), Methicillin (MESH:D008712), Temporin 1IDau1 (-), NO (MESH:D009569)
- **Species:** Batrachochytrium dendrobatidis (amphibian chytrid, species) [taxon 109871], Enterococcus faecalis (species) [taxon 1351], Pelophylax ridibundus (European green frog, species) [taxon 8406], Streptococcus uberis (species) [taxon 1349], human gammaherpesvirus 4 (Epstein Barr virus, no rank) [taxon 10376], Helicobacter pylori (species) [taxon 210], Klebsiella pneumoniae (species) [taxon 573], Escherichia coli (E. coli, species) [taxon 562], Rana chensinensis (Asiatic grass frog, species) [taxon 79015], Klebsiella pneumoniae subsp. pneumoniae (subspecies) [taxon 72407], Pasteurella multocida (species) [taxon 747], Pseudomonas aeruginosa (species) [taxon 287], aureus [taxon 46170], Phyllomedusa bicolor (two-colored leaf frog, species) [taxon 8393], Acinetobacter baumannii (species) [taxon 470], Enterobacter (genus) [taxon 547], Candida albicans (species) [taxon 5476], Enterococcus faecium (species) [taxon 1352], Staphylococcus epidermidis RP62A (strain) [taxon 176279], Homo sapiens (human, species) [taxon 9606], Xenopus laevis (African clawed frog, species) [taxon 8355], Leishmania (subgenus) [taxon 38568], Staphylococcus epidermidis (species) [taxon 1282], Salmonella enterica subsp. enterica serovar Typhi (no rank) [taxon 90370], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Human immunodeficiency virus 1 (no rank) [taxon 11676], Bos taurus (bovine, species) [taxon 9913], Staphylococcus aureus (species) [taxon 1280], Mus musculus (house mouse, species) [taxon 10090], Pseudomonas aeruginosa PAO1 (strain) [taxon 208964]
- **Mutations:** D27K, D20K
- **Cell lines:** H460 — Homo sapiens (Human), Lung large cell carcinoma, Cancer cell line (CVCL_0459), Calu-3 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0609), Jurkat T cell leukemia — Homo sapiens (Human), Childhood B acute lymphoblastic leukemia, Cancer cell line (CVCL_6G43), H1299 — Homo sapiens (Human), Lung large cell carcinoma, Cancer cell line (CVCL_0060), HepG2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027), H23 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_1547), LB-EBV — Homo sapiens (Human), EBV-related Burkitt lymphoma, Cancer cell line (CVCL_2027), A375 — Homo sapiens (Human), Amelanotic melanoma, Cancer cell line (CVCL_0132), S180 sarcoma — Mus musculus (Mouse), Mouse fibrosarcoma, Cancer cell line (CVCL_3598), A549 lung cancer — Homo sapiens (Human), Lung squamous cell carcinoma, Cancer cell line (CVCL_3008), Molt-4 — Homo sapiens (Human), Adult T acute lymphoblastic leukemia, Cancer cell line (CVCL_0013), MDA-MB-453 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0418), T98G — Homo sapiens (Human), Glioblastoma, Cancer cell line (CVCL_0556), U20S — Homo sapiens (Human), Osteosarcoma, Cancer cell line (CVCL_0042), PLC — Homo sapiens (Human), Adult hepatocellular carcinoma, Cancer cell line (CVCL_0485), Bcap-37 — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0164), C8166 — Homo sapiens (Human), Transformed cell line (CVCL_1099), U215MG — Homo sapiens (Human), Induced pluripotent stem cell (CVCL_JR08), MDA-MB-435S — Homo sapiens (Human), Amelanotic melanoma, Cancer cell line (CVCL_0622), ATCC 27853 — Homo sapiens (Human), Transformed cell line (CVCL_ZH96), U87MG — Homo sapiens (Human), Glioblastoma, Cancer cell line (CVCL_0022), P388 — Mus musculus (Mouse), Mouse lymphoma, Cancer cell line (CVCL_7222), MDA-MB-231 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0062), K. pneumoniae — Clarias batrachus (Walking catfish), Spontaneously immortalized cell line (CVCL_S935), A549 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023), NIH3T3 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0594), HTK — Homo sapiens (Human), Osteosarcoma, Cancer cell line (CVCL_2522), B16 — Mus musculus (Mouse), Hybridoma (CVCL_U043), MCF-7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031), B16-F10 — Mus musculus (Mouse), Mouse melanoma, Cancer cell line (CVCL_0159), RAJI — Homo sapiens (Human), EBV-related Burkitt lymphoma, Cancer cell line (CVCL_2699), Raw 264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493), BIU-87 — Unidentified organism (Unknown organism), Undefined cell line type (CVCL_6881), DU145 — Homo sapiens (Human), Prostate carcinoma, Cancer cell line (CVCL_0105), C4-2B — Homo sapiens (Human), Prostate carcinoma, Cancer cell line (CVCL_4784), PC3 — Homo sapiens (Human), Prostate carcinoma, Cancer cell line (CVCL_0035), U138MG — Homo sapiens (Human), Astrocytoma, Cancer cell line (CVCL_0020), MCF-7 breast cancer — Homo sapiens (Human), Transformed cell line (CVCL_WC49), H838 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_1594), TC-1 — Mus musculus (Mouse), Hybridoma (CVCL_G561), BJAB — Homo sapiens (Human), Burkitt lymphoma, Cancer cell line (CVCL_5711), BALB/c — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0184), MCF-10A — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_0598), HT-29 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0320), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030), HSC-4 — Homo sapiens (Human), Tongue squamous cell carcinoma, Cancer cell line (CVCL_1289), SK-MEL-28 — Homo sapiens (Human), Cutaneous melanoma, Cancer cell line (CVCL_0526), LK-2 — Homo sapiens (Human), Lung squamous cell carcinoma, Cancer cell line (CVCL_1377), Hep3B — Homo sapiens (Human), Childhood hepatocellular carcinoma, Cancer cell line (CVCL_0326), HeLa cervical cancer — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_JX14), H3122 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_5160), Jurkat — Homo sapiens (Human), Childhood T acute lymphoblastic leukemia, Cancer cell line (CVCL_0065), COS7 — Chlorocebus aethiops (Green monkey), Transformed cell line (CVCL_0224), B. subtilis — Opodiphthera eucalypti (Emperor gum moth), Spontaneously immortalized cell line (CVCL_C2VY), BEL7402 — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_5492), SkBr-3 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0033), SK-HEP-1 — Homo sapiens (Human), Liver and intrahepatic bile duct epithelial neoplasm, Cancer cell line (CVCL_0525), HT-144 — Homo sapiens (Human), Wolman disease, Induced pluripotent stem cell (CVCL_UD78), SMMC7721 — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0534), U937 — Homo sapiens (Human), Adult acute monocytic leukemia, Cancer cell line (CVCL_0007)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13023495/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC13023495/full.md

## References

203 references — full list in the complete paper: https://tomesphere.com/paper/PMC13023495/full.md

---
Source: https://tomesphere.com/paper/PMC13023495